Jbm (Healthcare) Ltd
HKEX:2161
Jbm (Healthcare) Ltd
HKEX:2161
Price:
0.86 HKD
-2.27%
Market Closed
Updated:
May 5, 2024
Jbm (Healthcare) Ltd
Cash from Investing Activities
|
Jbm (Healthcare) Ltd
Cash from Investing Activities Peer Comparison
Comparables:
U
3933
S
1177
C
570
C
3320
HCM
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Jbm (Healthcare) Ltd
HKEX:2161
|
Cash from Investing Activities
-HK$6.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
U
|
United Laboratories International Holdings Ltd
HKEX:3933
|
Cash from Investing Activities
-¥851m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-9%
|
CAGR 10-Years
4%
|
|
S
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
Cash from Investing Activities
-¥2.2B
|
CAGR 3-Years
35%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-15%
|
|
C
|
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
|
Cash from Investing Activities
-¥761.3m
|
CAGR 3-Years
11%
|
CAGR 5-Years
13%
|
CAGR 10-Years
6%
|
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
Cash from Investing Activities
HK$911m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
HUTCHMED (China) Ltd
LSE:HCM
|
Cash from Investing Activities
-$291.1m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-61%
|
See Also
What is Jbm (Healthcare) Ltd's Cash from Investing Activities?
Cash from Investing Activities
-6.8m
HKD
-6.8m
HKD
Based on the financial report for Mar 31, 2023, Jbm (Healthcare) Ltd's Cash from Investing Activities amounts to -6.8m HKD.
What is Jbm (Healthcare) Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
35%
35%
Over the last year, the Cash from Investing Activities growth was 10%.
You don't have any saved screeners yet
